FDA panel backs new Alzheimer’s drug, despite risks and uncertainties

FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly

Breaking Free From Antidepressants: Lancet Psychiatry Study Uncovers the Risks of Discontinuation Symptoms

Women Are More Likely to Get Drug-Resistant Infections